AMLX Amylyx Pharmaceuticals, Inc. 424B5

AMLX 424B5 filed August 20, 2026

Amylyx Pharmaceuticals, Inc.

This report is being refreshed

An automated blocking check flagged a hard inconsistency in this summary (for example, figures that fail a specific reconciliation), so we've held it back while it's regenerated. That doesn't mean every published report is perfect — only that this one hit a known blocker. Check back shortly, or read the original filing on SEC EDGAR now.

About this filing

Company
Amylyx Pharmaceuticals, Inc. (AMLX)
Form type
424B5
Filed
August 20, 2026
Accession
0001193125-26-359416